Here, we explored the connection between loss of IKZF1 function, AKT signaling and GC therapy resistance using an isogenic cell line model, normal B cells derived from Ikzf1+/- mice as well patient-derived ALL xenografts. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.